Merck Ordered to Pay $14 Million in Attorneys’ Fees to Rival Gilead After a Patent Infringement Trial Involving Hepatitis C Drugs -
On July 14, 2017, in a stunning reversal of fortune, a federal court in San Jose, CA,...more
8/5/2017
/ Appeals ,
Attorney's Fees ,
Confidential Information ,
Gilead Sciences ,
Jury Verdicts ,
Merck ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Willful Misconduct